BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 100 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,057 | -82.5% | 717 | -71.1% | 0.00% | – |
| Q2 2023 | $11,764 | +71.9% | 2,484 | -37.9% | 0.00% | – |
| Q1 2023 | $6,844 | +36.9% | 4,002 | +43.9% | 0.00% | – |
| Q4 2022 | $5,000 | +66.7% | 2,782 | +23.1% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 2,260 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -99.3% | 2,260 | -30.7% | 0.00% | -100.0% |
| Q1 2022 | $668,000 | +3611.1% | 3,260 | -3.7% | 0.00% | – |
| Q4 2021 | $18,000 | -30.8% | 3,387 | +10.0% | 0.00% | – |
| Q3 2021 | $26,000 | -36.6% | 3,080 | -6.1% | 0.00% | – |
| Q2 2021 | $41,000 | +173.3% | 3,280 | +420.6% | 0.00% | – |
| Q1 2021 | $15,000 | – | 630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |